Format

Send to

Choose Destination
Cell Stem Cell. 2011 Nov 4;9(5):397-401. doi: 10.1016/j.stem.2011.10.010.

The impact of market volatility on the cell therapy industry.

Author information

1
The Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London, WC1E 6BT, UK. david_brindley@harvard.edu

Abstract

Stock market volatility in the cell therapy industry has greatly hindered the investment necessary to fund translational therapies. Here, we review the volatility of leading companies and suggest that a distinct industry is maturing to a point at which the volatility should subside, providing a more attractive environment for future growth.

PMID:
22056137
DOI:
10.1016/j.stem.2011.10.010
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center